Reply to: Methotrexate toxicity and glucarpidase: A call for dose optimization. Koppen A, et al. Br J Clin Pharmacol. 2025;91(5):1289-1292 doi:10.1002/bcp.70044.
作者信息
Rizzari Carmelo, Schwartz Stefan
机构信息
Pediatric Hematology-Oncology Unit, Department of Pediatrics, IRCCS San Gerardo dei Tintori, Monza, Italy.
Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität and Humboldt-Universität zu Berlin, Campus Benjamin Franklin, Berlin, Germany.
出版信息
Br J Clin Pharmacol. 2025 Sep;91(9):2762-2763. doi: 10.1002/bcp.70105. Epub 2025 May 20.
Abstract
摘要
相似文献
1
Reply to: Methotrexate toxicity and glucarpidase: A call for dose optimization. Koppen A, et al. Br J Clin Pharmacol. 2025;91(5):1289-1292 doi:10.1002/bcp.70044.
Br J Clin Pharmacol. 2025 Sep;91(9):2762-2763. doi: 10.1002/bcp.70105. Epub 2025 May 20.
2
Reply to: 'Methotrexate toxicity and glucarpidase: A call for dose optimization'.
Br J Clin Pharmacol. 2025 Sep;91(9):2764-2766. doi: 10.1002/bcp.70164. Epub 2025 Jun 29.
3
Expression of Concern.
Eur Rev Med Pharmacol Sci. 2025 Jun;29(6):287-288. doi: 10.26355/eurrev_202506_37270.
4
Letter to the editor of the Brit J Clin Pharmacol on Heuberger et al. 2025 https://doi.org/10.1002/bcp.70090.
Br J Clin Pharmacol. 2025 Sep;91(9):2767. doi: 10.1002/bcp.70154. Epub 2025 Jun 20.
5
Trained ILCs confer adaptive immunity-independent protection against influenza.
J Virol. 2025 Aug 4:e0053225. doi: 10.1128/jvi.00532-25.
6
Framework for classifying chemicals for repeat dose toxicity using NAMs.
Arch Toxicol. 2025 May 24. doi: 10.1007/s00204-025-04069-1.
7
Does deprescribing in older people improve outcomes?
Drug Ther Bull. 2020 Sep;58(9):132. doi: 10.1136/dtb.2020.000041. Epub 2020 Jun 24.
8
A systematic review of the precision and accuracy of dose measurements in photon radiotherapy using polymer and Fricke MRI gel dosimetry.
Phys Med Biol. 2002 Oct 21;47(20):R107-21. doi: 10.1088/0031-9155/47/20/201.
9
Robotic versus open ventral hernia repair (ROVHR): a randomized controlled trial protocol.
Hernia. 2025 Mar 4;29(1):109. doi: 10.1007/s10029-025-03299-7.
10
Mycophenolate mofetil versus methotrexate for prevention of graft-versus-host disease in people receiving allogeneic hematopoietic stem cell transplantation.
Cochrane Database Syst Rev. 2014 Jul 25;2014(7):CD010280. doi: 10.1002/14651858.CD010280.pub2.
本文引用的文献
1
Methotrexate toxicity and glucarpidase: A call for dose optimization.
Br J Clin Pharmacol. 2025 May;91(5):1289-1292. doi: 10.1002/bcp.70044. Epub 2025 Mar 12.
2
Glucarpidase for treatment of high-dose methotrexate toxicity.
Blood. 2025 Apr 24;145(17):1858-1869. doi: 10.1182/blood.2024026211.
3
Routine use of low-dose glucarpidase following high-dose methotrexate in adult patients with CNS lymphoma: an open-label, multi-center phase I study.
BMC Cancer. 2022 Jan 13;22(1):60. doi: 10.1186/s12885-021-09164-x.
4
Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.
Oncologist. 2018 Jan;23(1):52-61. doi: 10.1634/theoncologist.2017-0243. Epub 2017 Oct 27.
5
Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis.
Kidney Int. 2012 Mar;81(5):442-8. doi: 10.1038/ki.2011.379. Epub 2011 Nov 23.
6
Glucarpidase (carboxypeptidase g2) intervention in adult and elderly cancer patients with renal dysfunction and delayed methotrexate elimination after high-dose methotrexate therapy.
Oncologist. 2007 Nov;12(11):1299-308. doi: 10.1634/theoncologist.12-11-1299.
Zotero 插件